Anavex Life Sciences Corp (AVXL)

[powerwalker]

Musing during a MoW route today:

1) If the Rett Excellence trial results are just that "Excellent," that BP's eyes are opened wider to the potential of small molecules and the validity of homeostasis, such that a low rumble will begin for one of them to buy-out Anavex, which would not maximize shareholder value in the long run? [BP is anxious to read the Rett numbers, too, as many are interested in small molecules and homeostasis.]

2) To minimize that threat, would Anavex then time the Rett release to a period slightly before the peer review paper on the Alzheimer's P2b/3 trail results, thus establishing a higher value for Anavex?

3) TGD has a problem if Alzheimer's peer review release goes into 2024, given his committed to release Rett this year.

IMO, the two are released within a week of each other in 2023 or Rett will be released mid-December if peer review is not forthcoming in 2023.